Revive Therapeutics Ltd (RVV) Stock Price & News

All values in CAD	2025-ж. июн.	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	336,32 миң	200,14 миң	283,25 миң	242,05 миң
Operating expense	336,39 миң	220,13 миң	283,30 миң	463,87 миң
Total operating expenses	336,39 миң	220,13 миң	283,30 миң	463,87 миң
Operating income	-336,39 миң	-220,13 миң	-283,30 миң	-463,87 миң
Other non operating income	73,85 миң	-	-	-
EBT including unusual items	-9,60 млн	-281,75 миң	-238,72 миң	-506,50 миң
EBT excluding unusual items	-143,94 миң	-281,75 миң	-234,70 миң	-506,50 миң
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-9,60 млн	-281,75 миң	-238,72 миң	-506,50 миң
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	277,00	-	-
Interest expense	-	-	-	-
Net interest expenses	-	277,00	-	-
Depreciation and amortization charges	62,00	46,00	48,00	47,00
EBITDA	-336,32 миң	-220,08 миң	-283,25 миң	-463,82 миң
Gain or loss from assets sale	-	-	-	-

Ask anything